|
1
|
Montelli A, Dowdeswell JA, Ottesen D and
Johansen SE: 3D seismic evidence of buried iceberg ploughmarks from
the mid-Norwegian continental margin reveals largely persistent
North Atlantic current through the quaternary. Mar Geol. 399:66–83.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kirkin AF, Dzhandzhugazyan KN and Zeuthen
J: Cancer/testis antigens: Structural and immunobiological
properties. Cancer Invest. 20:222–236. 2002.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kumar N, Sood D, Gupta A, Jha NK, Jain P
and Chandra R: Cytotoxic T-lymphocyte elicited therapeutic vaccine
candidate targeting cancer against MAGE-A11 carcinogenic protein.
Biosci Rep. 40(BSR20202349)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuldkepp A, Karakai M, Toomsoo E, Reinsalu
O and Kurg R: Cancer-testis antigens MAGEA proteins are
incorporated into extracellular vesicles released by cells.
Oncotarget. 10:3694–3708. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gao X, Li Q, Chen G, He H and Ma Y: MAGEA3
promotes proliferation and suppresses apoptosis in cervical cancer
cells by inhibiting the KAP1/p53 signaling pathway. Am J Transl
Res. 12:3596–3612. 2020.PubMed/NCBI
|
|
6
|
Pan SJ, Ren J, Jiang H, Liu W, Hu LY, Pan
YX, Sun B, Sun QF and Bian LG: MAGEA6 promotes human glioma cell
survival via targeting AMPKα1. Cancer Lett. 412:21–29.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pineda CT and Potts PR: Oncogenic
MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by
ubiquitinating and degrading AMPK in cancer. Autophagy. 11:844–846.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shukla SA, Bachireddy P, Schilling B,
Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D,
Keskin DB, et al: Cancer-germline antigen expression discriminates
clinical outcome to CTLA-4 blockade. Cell. 173:624–633.e8.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wong PP, Yeoh CC, Ahmad AS, Chelala C,
Gillett C, Speirs V, Jones JL and Hurst HC: Identification of MAGEA
antigens as causal players in the development of
tamoxifen-resistant breast cancer. Oncogene. 33:4579–4588.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schooten E, Di Maggio A, van Bergen En
Henegouwen PMP and Kijanka MM: MAGE-A antigens as targets for
cancer immunotherapy. Cancer Treat Rev. 67:54–62. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morgan RA, Chinnasamy N, Abate-Daga D,
Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry
RM, et al: Cancer regression and neurological toxicity following
anti-MAGE-A3 TCR gene therapy. J Immunother. 36:133–151.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hao J, Li S, Li J, Jiang Z, Ghaffar M,
Wang M, Jia R, Chen S, Wang Y and Zeng Y: Investigation into the
expression levels of MAGEA6 in esophageal squamous cell carcinoma
and esophageal adenocarcinoma tissues. Exp Ther Med. 18:1816–1822.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fon Tacer K, Montoya MC, Oatley MJ, Lord
T, Oatley JM, Klein J, Ravichandran R, Tillman H, Kim M, Connelly
JP, et al: MAGE cancer-testis antigens protect the mammalian
germline under environmental stress. Sci Adv.
5(eaav4832)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang Y, Zhang Y and Zhang L: Expression
of cancer-testis antigens in esophageal cancer and their progress
in immunotherapy. J Cancer Res Clin Oncol. 145:281–291.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sang M, Meng L, Sang Y, Liu S, Ding P, Ju
Y, Liu F, Gu L, Lian Y, Li J, et al: Circular RNA ciRS-7
accelerates ESCC progression through acting as a miR-876-5p sponge
to enhance MAGE-A family expression. Cancer Lett. 426:37–46.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lee TB, Lim SC, Moon YS and Choi CH:
Melanoma antigen gene family A as a molecular marker of gastric and
colorectal cancers. Oncol Rep. 30:234–238. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Guo JC, Yang YJ, Zhang JQ, Guo M, Xiang L,
Yu SF, Ping H and Zhuo L: microRNA-448 inhibits stemness
maintenance and self-renewal of hepatocellular carcinoma stem cells
through the MAGEA6-mediated AMPK signaling pathway. J Cell Physiol.
234:23461–23474. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jurisic V: Multiomic analysis of cytokines
in immuno-oncology. Expert Rev Proteomics. 17:663–674.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zou C, Shen J, Tang Q, Yang Z, Yin J, Li
Z, Xie X, Huang G, Lev D and Wang J: Cancer-testis antigens
expressed in osteosarcoma identified by gene microarray correlate
with a poor patient prognosis. Cancer. 118:1845–1855.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hilal NR, Novikov DV, Novikov VV and
Karaulov AV: Cancer-testis genes in colon cancer. Ter Arkh.
89:113–117. 2017.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
|
22
|
Bredenbeck A, Hollstein VM, Trefzer U,
Sterry W, Walden P and Losch FO: Coordinated expression of
clustered cancer/testis genes encoded in a large inverted repeat
DNA structure. Gene. 415:68–73. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Atanackovic D, Hildebrandt Y, Jadczak A,
Cao Y, Luetkens T, Meyer S, Kobold S, Bartels K, Pabst C, Lajmi N,
et al: Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the
survival of multiple myeloma cells. Haematologica. 95:785–793.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zajac P, Schultz-Thater E, Tornillo L,
Sadowski C, Trella E, Mengus C, Iezzi G and Spagnoli GC: MAGE-A
antigens and cancer immunotherapy. Front Med (Lausanne).
4(18)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Willett CS and Wilson EM: Evolution of
melanoma antigen-A11 (MAGEA11) during primate phylogeny. J Mol
Evol. 86:240–253. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tang WW, Liu ZH, Yang TX, Wang HJ and Cao
XF: Upregulation of MAGEA4 correlates with poor prognosis in
patients with early stage of esophageal squamous cell carcinoma.
Onco Targets Ther. 9:4289–4293. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Meek DW and Marcar L: MAGE-A antigens as
targets in tumour therapy. Cancer Lett. 324:126–132.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Laiseca JE, Ladelfa MF, Cotignola J, Peche
LY, Pascucci FA, Castaño BA, Galigniana MD, Schneider C and Monte
M: Functional interaction between co-expressed MAGE-A proteins.
PLoS One. 12(e0178370)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yang P, Huo Z, Liao H and Zhou Q:
Cancer/testis antigens trigger epithelial-mesenchymal transition
and genesis of cancer stem-like cells. Curr Pharm Des.
21:1292–1300. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tauber C, Schultheiss M, Luca R, Buettner
N, Llewellyn-Lacey S, Emmerich F, Zehe S, Price DA,
Neumann-Haefelin C, Schmitt-Graeff A, et al: Inefficient induction
of circulating TAA-specific CD8+ T-cell responses in hepatocellular
carcinoma. Oncotarget. 10:5194–5206. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Baran CA, Agaimy A, Wehrhan F, Weber M,
Hille V, Brunner K, Wickenhauser C, Siebolts U, Nkenke E, Kesting M
and Ries J: MAGE-A expression in oral and laryngeal leukoplakia
predicts malignant transformation. Mod Pathol. 32:1068–1081.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen X, Cai S, Wang L, Zhang X, Li W and
Cao X: Analysis of the function of MAGE-A in esophageal carcinoma
by bioinformatics. Medicine (Baltimore). 98(e15774)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ervin JM, Schütz LF and Spicer LJ: Current
status of the role of endothelins in regulating ovarian follicular
function: A review. Anim Reprod Sci. 186:1–10. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Brancaccio M, Natale F, Falco G and
Angrisano T: Cell-free DNA methylation: The new frontiers of
pancreatic cancer biomarkers' discovery. Genes (Basel).
11(14)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wiszniewski W, Hunter JV, Hanchard NA,
Willer JR, Shaw C, Tian Q, Illner A, Wang X, Cheung SW, Patel A, et
al: TM4SF20 ancestral deletion and susceptibility to a pediatric
disorder of early language delay and cerebral white matter
hyperintensities. Am J Hum Genet. 93:197–210. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Puissant MM, Muere C, Levchenko V, Manis
AD, Martino P, Forster HV, Palygin O, Staruschenko A and Hodges MR:
Genetic mutation of Kcnj16 identifies Kir5.1-containing channels as
key regulators of acute and chronic pH homeostasis. FASEB J.
33:5067–5075. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jabara HH, Boyden SE, Chou J, Ramesh N,
Massaad MJ, Benson H, Bainter W, Fraulino D, Rahimov F, Sieff C, et
al: A missense mutation in TFRC, encoding transferrin receptor 1,
causes combined immunodeficiency. Nat Genet. 48:74–78.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sato Y, Inokuchi M, Takagi Y and Kojima K:
IGFBP1 is a predictive factor for haematogenous metastasis in
patients with gastric cancer. Anticancer Res. 39:2829–2837.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Andrew M, Liao L, Fujimoto M, Khoury J,
Hwa V and Dauber A: PAPPA2 as a therapeutic modulator of IGF-I
bioavailability: In vivo and in vitro evidence. J Endocr Soc.
2:646–656. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu K, Li L, Li L and Wang D: Long
non-coding RNA HAL suppresses the migration and invasion of serous
ovarian cancer by inhibiting EMT signaling pathway. Biosci Rep.
40(BSR20194496)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Jiang H, Liu Y, Qian Y, Shen Z, He Y, Gao
R, Shen M, Chen S, Fu Q and Yang T: CHL1 promotes insulin secretion
and negatively regulates the proliferation of pancreatic β cells.
Biochem Biophys Res Commun. 525:1095–1102. 2020.PubMed/NCBI View Article : Google Scholar
|
